The TLR3 agonist Poly(I:C) induced the expression of the IRF3 target genes IFNB and CXCL10 in all tested cancer cell lines suggesting that defects upstream of TBK1/IKKe render the cancer cells unresponsive to STING agonists (Fig. 1D). This evidence concerns the gene CXCL10 and cancer.